| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.IJCARD.2014.10.144 |
| P698 | PubMed publication ID | 25464262 |
| P50 | author | Masako Tanaka | Q82306912 |
| P2093 | author name string | Soichi Sano | |
| Yasuhiro Nakamura | |||
| Minoru Yoshiyama | |||
| Kenei Shimada | |||
| Hiroshi Iwao | |||
| Masayuki Shiota | |||
| Yasukatsu Izumi | |||
| Mayuko Osada-Oka | |||
| Takehiro Yamaguchi | |||
| Takanori Yamazaki | |||
| Katuyuki Miura | |||
| P921 | main subject | myocardial infarction | Q12152 |
| ventricular remodeling | Q7920323 | ||
| chronic heart failure | Q11829287 | ||
| P304 | page(s) | 239-246 | |
| P577 | publication date | 2014-10-30 | |
| P1433 | published in | International Journal of Cardiology | Q2357863 |
| P1476 | title | Repeated remote ischemic conditioning attenuates left ventricular remodeling via exosome-mediated intercellular communication on chronic heart failure after myocardial infarction | |
| P478 | volume | 178 |
| Q39049805 | Association of remote ischemic peri-conditioning with reduced incidence of clinical heart failure after primary percutaneous coronary intervention |
| Q37448086 | Astragaloside IV enhances cardioprotection of remote ischemic conditioning after acute myocardial infarction in rats |
| Q47137765 | Beneficial effects of exosomes secreted by cardiac-derived progenitor cells and other cell types in myocardial ischemia. |
| Q26770294 | Cardiac Extracellular Vesicles in Normal and Infarcted Heart |
| Q92103360 | Chronic remote ischemic conditioning for cardiovascular protection |
| Q36081700 | DNA Content in Extracellular Vesicles Isolated from Porcine Coronary Venous Blood Directly after Myocardial Ischemic Preconditioning. |
| Q53790696 | Daily remote ischaemic conditioning following acute myocardial infarction: a randomised controlled trial. |
| Q64244712 | Delayed Remote Ischemic Preconditioning ConfersRenoprotection against Septic Acute Kidney Injury via Exosomal miR-21 |
| Q52353228 | Do platelets promote cardiac recovery post myocardial infarction: Roles beyond occlusive ischemic damage. |
| Q64940600 | Effect of Ischemic Preconditioning and Postconditioning on Exosome-Rich Fraction microRNA Levels, in Relation with Electrophysiological Parameters and Ventricular Arrhythmia in Experimental Closed-Chest Reperfused Myocardial Infarction. |
| Q88565125 | Effect of comprehensive remote ischemic conditioning in anterior ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: Design and rationale of the CORIC-MI randomized trial |
| Q46311969 | Engineering of extracellular vesicles as drug delivery vehicles |
| Q55258920 | Enhanced Local Skeletal Muscle Oxidative Capacity and Microvascular Blood Flow Following 7-Day Ischemic Preconditioning in Healthy Humans. |
| Q57794663 | Evaluation of the cardioprotective potential of extracellular vesicles - a systematic review and meta-analysis |
| Q55497478 | Examining the Paracrine Effects of Exosomes in Cardiovascular Disease and Repair. |
| Q94540547 | Exosomal MicroRNA-126 from RIPC Serum Is Involved in Hypoxia Tolerance in SH-SY5Y Cells by Downregulating DNMT3B |
| Q26746950 | Exosome: A Novel Approach to Stimulate Bone Regeneration through Regulation of Osteogenesis and Angiogenesis |
| Q45974468 | Exosomes as agents of change in the cardiovascular system. |
| Q28081616 | Exosomes for Intramyocardial Intercellular Communication |
| Q90599368 | Exosomes in Coronary Artery Disease |
| Q41001027 | Exosomes: A Rising Star in Falling Hearts |
| Q55416682 | Exosomes: a novel therapeutic target for Alzheimer's disease? |
| Q90407419 | Exosomes: mediators of bone diseases, protection, and therapeutics potential |
| Q96303273 | Extracellular Vesicles as Therapeutic Agents for Cardiac Fibrosis |
| Q57178359 | Extracellular microRNAs and oxidative stress in liver injury: a systematic mini review |
| Q37204128 | Extracellular vesicle microRNAs mediate skeletal muscle myogenesis and disease |
| Q38430673 | Extracellular vesicles and atherosclerotic disease |
| Q99623721 | Extracellular vesicles and cardiovascular system: Biomarkers and Cardioprotective Effectors |
| Q33362561 | Extracellular vesicles in cardiovascular disease: are they Jedi or Sith? |
| Q36360209 | From Protecting the Heart to Improving Athletic Performance - the Benefits of Local and Remote Ischaemic Preconditioning. |
| Q92928261 | Hypoxia preconditioned renal tubular epithelial cell-derived extracellular vesicles alleviate renal ischaemia-reperfusion injury mediated by the HIF-1α/Rab22 pathway and potentially affected by microRNAs |
| Q58793281 | Improvements in long standing cardiac pathologies by individualized homeopathic remedies: A case series |
| Q92243717 | Long Noncoding RNAs in Pathological Cardiac Remodeling: A Review of the Update Literature |
| Q50284988 | Mechanisms of vascular comorbidity in autoimmune diseases |
| Q40963741 | Myocardial ischemic preconditioning in a porcine model leads to rapid changes in cardiac extracellular vesicle messenger RNA content |
| Q96127279 | Native and bioengineered extracellular vesicles for cardiovascular therapeutics |
| Q38804978 | New strategies for improving stem cell therapy in ischemic heart disease |
| Q90667262 | Noncoding RNAs regulating cardiac muscle mass |
| Q92103352 | Peripheral Mechanisms of Remote Ischemic Conditioning |
| Q55313626 | Plasma exosomes induced by remote ischaemic preconditioning attenuate myocardial ischaemia/reperfusion injury by transferring miR-24. |
| Q64068107 | Potential Applications of Remote Limb Ischemic Conditioning for Chronic Cerebral Circulation Insufficiency |
| Q90674393 | Quantification of DNA Damage in Different Tissues in Rats with Heart Failure |
| Q38833919 | Remote ischaemic conditioning and remodelling following myocardial infarction: current evidence and future perspectives |
| Q28078462 | Remote ischaemic conditioning in the context of type 2 diabetes and neuropathy: the case for repeat application as a novel therapy for lower extremity ulceration |
| Q38574681 | Resuscitation of a dead cardiomyocyte |
| Q38652143 | Stem cell-derived exosomes: A promising strategy for fracture healing. |
| Q47117835 | Systemic redistribution of the intramyocardially injected mesenchymal stem cells by repeated remote ischaemic post-conditioning. |
| Q58998162 | Targeting miRNA for Therapy of Juvenile and Adult Diabetic Cardiomyopathy |
| Q54976732 | The Cardioprotective Effects of 4-O-(2″-O-acetyl-6″-O- P-coumaroyl-β-D-glucopyranosyl)-P-coumaric Acid (4-ACGC) on Chronic Heart Failure. |
| Q38660549 | The application of remote ischemic conditioning in cardiac surgery |
Search more.